Popular
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
CME/CEFAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
First-line Chemotherapy Options in Metastatic PDAC
MinuteCE®First-line Chemotherapy Options in Metastatic PDAC
0.25 program creditsPersonalizing Care Within the RCC Treatment Paradigm
CME/CEPersonalizing Care Within the RCC Treatment Paradigm
1.00 creditsCollaborative Insights to Solve the Puzzle of Bladder Cancer
CME/CECollaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credits- CME/CE Meeting
April 29, 2025
San Diego, California
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
CardiologyKidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Programs
Second-line Chemotherapy Options in Metastatic PDAC
MinuteCE®Second-line Chemotherapy Options in Metastatic PDAC
0.25 program creditsPatient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CEPatient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
0.25 creditsKidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
CardiologyKidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE Live BroadcastApril 29, 2025
03:00 PM - 04:00 PM ET
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
FINE-HEART Pooled Analysis
CardiologyFINE-HEART Pooled Analysis
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
ACC Action CenterSemaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
Clinical Practice
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
CardiologyMode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
- MinuteCE®
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
0.25 credits 2 episodes Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
CardiologyAnalysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Clinician's RoundtableAI and Hair Loss: Measuring Progress with Data-Driven Insights
Challenges in AI-Driven Dermatology: Understanding Current Limitations
Clinician's RoundtableChallenges in AI-Driven Dermatology: Understanding Current Limitations
Doctors Lounge
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
On the Frontlines of OsteoporosisDisparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
AI-Powered Virtual Hospital in China to Launch Public Pilot in 2025
Clinician's RoundtableAI-Powered Virtual Hospital in China to Launch Public Pilot in 2025
New AI Dataset Advances Dermatology for Darker Skin Tones
Clinician's RoundtableNew AI Dataset Advances Dermatology for Darker Skin Tones
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Clinician's RoundtableAI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
CHOP’s AI Tool CelloType Could Redefine Tumor Analysis
Clinician's RoundtableCHOP’s AI Tool CelloType Could Redefine Tumor Analysis
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Clinician's RoundtableInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
CME
PH Management in Unique Patients and Conditions
CME/CE Live BroadcastJune 24, 2025
12:00 PM - 01:00 PM EDT
PH Management in Unique Patients and Conditions
- CME/CE Meeting
May 01, 2025
Washington, DC, District of Columbia
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
Impact of Barostim on Heart Failure Hospitalization
CME/CEImpact of Barostim on Heart Failure Hospitalization
Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function
MinuteCE®
0.52 program creditsEchocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
MinuteCE®Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 program creditsUnderstanding hypertrophic cardiomyopathy and recent guidelines
MinuteCE®Understanding hypertrophic cardiomyopathy and recent guidelines
0.52 program credits
Industry Feature
Advancing Cardiology and Heart Surgery Through a History of Collaboration
Medical Industry FeatureAdvancing Cardiology and Heart Surgery Through a History of Collaboration
Neoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC
Medical Industry FeatureNeoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC
Novel Transcatheter Solution Approved for Tricuspid Regurgitation
Medical Industry FeatureNovel Transcatheter Solution Approved for Tricuspid Regurgitation
Beyond Symptom Control: Treating the Root Cause of House Dust Mite Allergies
Medical Industry FeatureBeyond Symptom Control: Treating the Root Cause of House Dust Mite Allergies
Biosimilar Access: Addressing Barriers to Build a Sustainable Marketplace
Medical Industry FeatureBiosimilar Access: Addressing Barriers to Build a Sustainable Marketplace
Examining a Therapeutic Modality for 2L+ mNSCLC
Medical Industry FeatureExamining a Therapeutic Modality for 2L+ mNSCLC